|
US2021040229A1
|
|
Methods for treating conditions associated with masp-2 dependent complement activation
|
|
WO2020146795A1
|
|
Methods and compositions for treating cancer
|
|
US2020276190A1
|
|
Inhibitors of GPR174 and Uses Thereof
|
|
AU2019288459A1
|
|
Compositions and methods of inhibiting MASP-2 for the treatment of various thrombotic diseases and disorders
|
|
US2019367452A1
|
|
Masp-2 inhibitors and methods of use
|
|
AU2019277150A1
|
|
MASP-2 inhibitors and methods of use
|
|
KR20200037863A
|
|
Highly concentrated low viscosity MASP-2 inhibitory antibody preparations, kits, and methods of treating subjects suffering from atypical hemolytic syndrome
|
|
TW201920288A
|
|
Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant
|
|
AU2017277288A1
|
|
Monoclonal antibodies, compositions and methods for detecting mucin -like protein (MLP) as a biomarker for ovarian and pancreatic cancer
|
|
WO2017173290A1
|
|
Methods for inhibiting angiogenesis in a subject in need thereof
|
|
KR20180074789A
|
|
Methods of treating diseases associated with MASP-2 dependent complement activation
|
|
MA42711A1
|
|
Methods of treating pathological conditions associated with activation of masp-2-dependent complement
|
|
CA3003611A1
|
|
Solid state forms of a pde10 inhibitor
|
|
JOP20170170A1
|
|
Highly concentrated low viscosity masp-2 inhibitory antibody formulations, kits, and methods
|
|
EP3285760A1
|
|
Pde10 inhibitors and related compositions and methods
|
|
AU2016201834A1
|
|
Ophthalmologic irrigation solutions and method
|
|
US2016228580A1
|
|
Mixed micelles
|
|
JOP20170154A1
|
|
Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
|
|
AU2015271989A1
|
|
Methods for treating conditions associated with MASP-2 dependent complement activation
|
|
TW201620514A
|
|
Anti-inflammatory and mydriatic intracameral solutions for inhibition of postoperative ocular inflammatory conditions
|
